Outer Biosciences

Outer Biosciences is a private, pre-revenue biotech startup based in Cambridge, MA, operating at the intersection of aging, longevity, and metabolic health with a specific focus on skin. The company's core asset is a fully-integrated technology platform that combines long-lasting, clinically-relevant ex vivo human skin models with multimodal data analysis and predictive machine learning to discover novel bioactives at scale. Led by a team with expertise in advanced organ systems engineering, Outer Biosciences aims to revolutionize the discovery of ingredients for the cosmetic and skincare industries by offering a more predictive and efficient alternative to traditional methods. Its approach promises to yield safer and more efficacious compounds for skin health applications.

A fully-integrated discovery platform combining complex, long-lasting, clinically-relevant ex vivo human skin models with multimodal data analysis and predictive machine learning to identify novel bioactive compounds for skin health.

Outer Biosciences competes in the emerging 'beauty bio-tech' space against other startups using synthetic biology, fermentation, and advanced screening methods for ingredient discovery. It also competes indirectly with large, established cosmetic ingredient suppliers and the in-house R&D departments of major beauty conglomerates. Its differentiation lies in the specific use of complex ex vivo skin models integrated with AI.